Pelthos Therapeutics (PTHS) Retained Earnings (2022 - 2026)
Pelthos Therapeutics (PTHS) posted quarterly Retained Earnings of -$64.8 million for Q4 2025, down 445.37% year-over-year from $18.8 million in Q4 2024, and down 50.23% quarter-over-quarter from -$43.1 million in Q3 2025.
Pelthos Therapeutics (PTHS) Retained Earnings (2022 - 2026) Analysis & Trends
Pelthos Therapeutics' Retained Earnings history runs 4 years deep, the most recent figure standing at -$64.8 million for Q4 2025.
- In Q4 2025, Retained Earnings fell 445.37% year-over-year to -$64.8 million; the TTM figure through Dec 2025 stood at -$64.8 million (down 445.37% YoY), while the FY2025 annual figure was -$64.8 million, down 445.37% from the prior year.
- Retained Earnings for Q4 2025 stood at -$64.8 million, down from -$43.1 million in the prior quarter.
- The five-year high for Retained Earnings was $20.4 million in Q2 2025, with the low at -$64.8 million in Q4 2025.
- The 4-year median for Retained Earnings is -$11.1 million (2022), against an average of -$10.9 million.
- The sharpest annual moves came in 2023 and 2025: Retained Earnings surged 215.24% in 2023, then slumped 445.37% in 2025.
- Pelthos Therapeutics' Retained Earnings stood at -$6.1 million in 2022, then soared by 215.24% to $7.1 million in 2023, then surged by 165.19% to $18.8 million in 2024, then plunged by 445.37% to -$64.8 million in 2025.
- Business Quant data shows PTHS's Retained Earnings at -$64.8 million in Q4 2025, -$43.1 million in Q3 2025, and $20.4 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 558.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 5.10 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 13.05 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -6.33 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 20.91 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 6.57 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 4.38 Bn |
| 10 | Pelthos Therapeutics | 91.09 Mn | 66.53 Mn | 21.23 Mn | -113.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -113.28 Mn |
| Dec 31, 2025 | -64.79 Mn |
| Sep 30, 2025 | -43.13 Mn |
| Jun 30, 2025 | 20.40 Mn |
| Mar 31, 2025 | -23.44 Mn |
| Dec 31, 2024 | 18.76 Mn |
| Sep 30, 2024 | -19.55 Mn |
| Jun 30, 2024 | 17.67 Mn |
| Mar 31, 2024 | -16.08 Mn |
| Dec 31, 2023 | 7.07 Mn |
| Dec 31, 2022 | -6.14 Mn |